Company Cytori Therapeutics Inc Nasdaq
Equities
US23283K4022
Biotechnology & Medical Research
Business Summary
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Pharmaceutical
100.0
%
| 0 | 100.0 % | 5 | 100.0 % | +2,093.30% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 5 | 100.0 % | +2,093.30% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Andrew Sims
DFI | Director of Finance/CFO | 51 | 20-02-05 |
Pius Maliakal
CTO | Chief Tech/Sci/R&D Officer | - | 23-07-26 |
Norman LaFrance
CTO | Chief Tech/Sci/R&D Officer | 76 | 21-12-07 |
Russ Havranek
PRN | Corporate Officer/Principal | - | 13-12-31 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Marc Hedrick
CEO | Chief Executive Officer | 61 | 02-09-30 |
Richard Hawkins
CHM | Chairman | 75 | 07-11-30 |
Robert Lenk
BRD | Director/Board Member | 75 | 20-02-29 |
J. Clowes
BRD | Director/Board Member | 70 | 20-02-29 |
Greg Petersen
BRD | Director/Board Member | 61 | 20-02-13 |
Director/Board Member | 64 | 19-12-31 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 4,354,641 | 4,214,074 ( 96.77 %) | 78,559 ( 1.804 %) | 96.77 % |
Company contact information
Plus Therapeutics, Inc.
4200 Marathon Boulevard Suite 200
78756, Austin
+737 255 7194
http://www.plustherapeutics.comSector
1st Jan change | Capi. | |
---|---|---|
+23.37% | 46.71B | |
+48.83% | 41.8B | |
-0.94% | 41.52B | |
-5.86% | 29.55B | |
+11.29% | 25.78B | |
-20.92% | 19.26B | |
+3.20% | 12.14B | |
-2.67% | 12.08B | |
+30.23% | 11.98B |